Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Gnanapragasam, V. J."" wg kryterium: Autor


Tytuł :
Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation.
Autorzy :
Parry MG; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. .; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England. .
Cowling TE; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Sujenthiran A; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England.
Nossiter J; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England.
Berry B; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, England.
Cathcart P; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Aggarwal A; Department of Cancer Epidemiology, Population, and Global Health, King's College London, London, UK.; Department of Radiotherapy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Payne H; Department of Oncology, University College London Hospitals, London, UK.
van der Meulen J; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester, UK.; Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK.
Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.; Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, Cambridge, UK.
Pokaż więcej
Źródło :
BMC medicine [BMC Med] 2020 May 28; Vol. 18 (1), pp. 114. Date of Electronic Publication: 2020 May 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Prostatic Neoplasms/*therapy
Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Prognosis ; Risk Factors
Czasopismo naukowe
Tytuł :
Three-year experience of a dedicated prostate mpMRI pre-biopsy programme and effect on timed cancer diagnostic pathways.
Autorzy :
Barrett T; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. Electronic address: .
Slough R; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Sushentsev N; Sechenov Biomedical Science & Technology Park, Sechenov First Moscow State Medical University, Moscow, Russia.
Shaida N; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Koo BC; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Caglic I; Department of Radiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
Kozlov V; Department of Public Health and Healthcare Organisation, Sechenov First Moscow State Medical University, Moscow, Russia.
Warren AY; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.
Thankappannair V; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.
Pinnock C; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Clinical Excellence Research Centre, Stanford University School of Medicine, California, USA.
Shah N; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.
Saeb-Parsy K; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.
Gnanapragasam VJ; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.
Sala E; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK.
Kastner C; CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.
Pokaż więcej
Źródło :
Clinical radiology [Clin Radiol] 2019 Nov; Vol. 74 (11), pp. 894.e1-894.e9. Date of Electronic Publication: 2019 Jul 06.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging/*methods
Prostate/*pathology
Prostatic Neoplasms/*pathology
Aged ; Critical Pathways ; Early Detection of Cancer ; Humans ; Image-Guided Biopsy/methods ; Male ; Middle Aged ; Neoplasm Grading ; Prospective Studies ; Retrospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Improving the safety and tolerability of local anaesthetic outpatient transperineal prostate biopsies: A pilot study of the CAMbridge PROstate Biopsy (CAMPROBE) method.
Autorzy :
Thurtle D; Academic Urology Group, University of Cambridge, Cambridge, UK.; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.
Starling L; Academic Urology Group, University of Cambridge, Cambridge, UK.; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials, University of Cambridge, Cambridge, UK.
Leonard K; Academic Urology Group, University of Cambridge, Cambridge, UK.; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials, University of Cambridge, Cambridge, UK.
Stone T; Medical Physics and Clinical Engineering, Addenbrooke's Hospital, Cambridge, UK.
Gnanapragasam VJ; Academic Urology Group, University of Cambridge, Cambridge, UK.; Department of Urology, Addenbrooke's Hospital, Cambridge, UK.; Cambridge Urology Translational Research and Clinical Trials, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Journal of clinical urology [J Clin Urol] 2018 May; Vol. 11 (3), pp. 192-199. Date of Electronic Publication: 2018 Mar 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A comparison of operative and margin outcomes from surgeon learning curves in robot assisted radical prostatectomy in a changing referral practice.
Autorzy :
Jaulim A; Cambridge University Hospitals NHS Foundation Trust , UK.; Contributed equally.
Srinivasan A; Cambridge University Hospitals NHS Foundation Trust , UK.; Contributed equally.
Hori S; Cambridge University Hospitals NHS Foundation Trust , UK.; Contributed equally.
Kumar N; Cambridge University Hospitals NHS Foundation Trust , UK.
Warren AY; Cambridge University Hospitals NHS Foundation Trust , UK.
Shah NC; Cambridge University Hospitals NHS Foundation Trust , UK.
Gnanapragasam VJ; Cambridge University Hospitals NHS Foundation Trust , UK.
Pokaż więcej
Źródło :
Annals of the Royal College of Surgeons of England [Ann R Coll Surg Engl] 2018 Mar; Vol. 100 (3), pp. 226-229. Date of Electronic Publication: 2018 Feb 27.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article
MeSH Terms :
Learning Curve*
Margins of Excision*
Robotic Surgical Procedures*
Prostatectomy/*methods
Prostatic Neoplasms/*surgery
Referral and Consultation/*statistics & numerical data
Adult ; Aged ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Prospective Studies ; Prostatic Neoplasms/pathology ; Risk ; Treatment Outcome ; United Kingdom
Czasopismo naukowe
Tytuł :
The Cambridge Prognostic Groups for improved prediction of disease mortality at diagnosis in primary non-metastatic prostate cancer: a validation study.
Autorzy :
Gnanapragasam VJ; Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. .; Addenbrookes Hospital, Department of Urology, Addenbrooke's Hospital, Cambridge, UK. .
Bratt O; Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden.
Muir K; Institute of Population Health, University of Manchester, Manchester, UK.
Lee LS; Department of Urology, Singapore General Hospital, Singapore, Singapore.
Huang HH; Department of Urology, Singapore General Hospital, Singapore, Singapore.
Stattin P; Department of Surgical and Perioperative Science, Urology and Andrology, Umeå University, Umeå, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Lophatananon A; Institute of Population Health, University of Manchester, Manchester, UK.
Pokaż więcej
Źródło :
BMC medicine [BMC Med] 2018 Feb 28; Vol. 16 (1), pp. 31. Date of Electronic Publication: 2018 Feb 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mortality/*trends
Prostatic Neoplasms/*diagnosis
Cohort Studies ; Humans ; Male ; Prognosis ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Survival Rate
Czasopismo naukowe
Tytuł :
Novel three-dimensional bone 'mapping' software can help assess progression of osseous metastases from routine CT.
Autorzy :
Thurtle D; Academic Urology Group, Department of Surgery, University of Cambridge, Box 279, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK. .; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK. .
Treece GM; Medical Imaging Group, Department of Engineering, University of Cambridge, Trumpington Street, Cambridge, CB2 1PZ, UK.
Barrett T; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.; Department of Radiology, University of Cambridge School of Clinical Medicine, Hills Road, Cambridge, CB2 0QQ, UK.
Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Box 279, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2017 Aug 30; Vol. 12 (1), pp. 143. Date of Electronic Publication: 2017 Aug 30.
Typ publikacji :
Journal Article
MeSH Terms :
Software*
Bone Neoplasms/*diagnostic imaging
Imaging, Three-Dimensional/*methods
Neoplasm Metastasis/*diagnostic imaging
Tomography, X-Ray Computed/*methods
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/secondary ; Bone Neoplasms/secondary ; Disease Progression ; Humans ; Image Interpretation, Computer-Assisted/methods ; Male ; Prostatic Neoplasms/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer.
Autorzy :
Patel KM; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Academic Urology Group, Department of Surgery & Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
van der Vos KE; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Smith CG; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Mouliere F; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Tsui D; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Morris J; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Chandrananda D; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Marass F; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
van den Broek D; Department of Clinical Chemistry, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Neal DE; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Nuffield Department of Surgery, Old Road Campus Research Building, University of Oxford, Oxford, OX3 7DQ, UK.
Gnanapragasam VJ; Academic Urology Group, Department of Surgery & Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Forshew T; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; UCL cancer Institute, Huntley St, Camden Town, London, WC1E 6DD, UK.
van Rhijn BW; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
Massie CE; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Rosenfeld N; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. .; Cancer Research UK Cambridge Cancer Centre, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. .
van der Heijden MS; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. .; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2017 Jul 17; Vol. 7 (1), pp. 5554. Date of Electronic Publication: 2017 Jul 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
DNA, Neoplasm/*blood
DNA, Neoplasm/*urine
Urinary Bladder Neoplasms/*genetics
Aged ; Female ; Follow-Up Studies ; Genome, Human ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local/genetics ; Treatment Outcome ; Urinary Bladder Neoplasms/mortality ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Corrigendum to "Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity" [Mol. Cell Endocrinol. 440 (2016) 138-150].
Autorzy :
Nelson AW; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, CB2 0QQ, UK; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Groen AJ; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK.
Miller JL; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK.
Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Holmes KA; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK.
Tarulli GA; Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute Building, School of Medicine, Faculty of Health Sciences, The University of Adelaide, SA 5005, Australia.
Tilley WD; Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute Building, School of Medicine, Faculty of Health Sciences, The University of Adelaide, SA 5005, Australia.
Katzenellenbogen BS; Departments of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Hawse JR; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK; Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, UK.
Carroll JS; Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 ORE, UK. Electronic address: .
Pokaż więcej
Źródło :
Molecular and cellular endocrinology [Mol Cell Endocrinol] 2017 Mar 05; Vol. 443, pp. 175.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].
Autorzy :
Ross-Adams H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Lamb AD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK. Electronic address: .
Dunning MJ; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Halim S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Lindberg J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Massie CM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Egevad LA; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Russell R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Ramos-Montoya A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Vowler SL; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Sharma NL; Nuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK. Electronic address: .
Kay J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK. Electronic address: .
Whitaker H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK. Electronic address: .
Clark J; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: .
Hurst R; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: .
Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK. Electronic address: .
Shah NC; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: .
Warren AY; Department of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: .
Cooper CS; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK. Electronic address: .
Lynch AG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Stark R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address: .
Mills IG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway; Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK. Electronic address: .
Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: .
Neal DE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address: .
Pokaż więcej
Corporate Authors :
CamCaP Study Group
Źródło :
EBioMedicine [EBioMedicine] 2017 Mar; Vol. 17, pp. 238. Date of Electronic Publication: 2017 Mar 08.
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population.
Autorzy :
Gnanapragasam VJ; Academic Urology Group, University of Cambridge, Box 279 (S4) Cambridge Biomedical Campus Cambridge CB2 0QQ, UK.; CamPARI Clinic, Box 41, Clinic 4A, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.; Department of Urology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Burling K; Core Biochemical Assay Laboratory, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
George A; Academic Urology Group, University of Cambridge, Box 279 (S4) Cambridge Biomedical Campus Cambridge CB2 0QQ, UK.
Stearn S; Academic Urology Group, University of Cambridge, Box 279 (S4) Cambridge Biomedical Campus Cambridge CB2 0QQ, UK.
Warren A; Department of Pathology, Cambridge University Hospitals Trust,Cambridge CB2 0QQ UK.
Barrett T; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ UK.; Department of Radiology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Koo B; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ UK.
Gallagher FA; Department of Radiology, University of Cambridge, Cambridge CB2 0QQ UK.; Department of Radiology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Doble A; CamPARI Clinic, Box 41, Clinic 4A, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.; Department of Urology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Kastner C; CamPARI Clinic, Box 41, Clinic 4A, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.; Department of Urology, Cambridge University Hospitals Trust, Cambridge CB2 0QQ UK.
Parker RA; Edinburgh Clinical Trials Unit University of Edinburgh, Usher Institute of Population Health Sciences and Informatics, Edinburgh EH89AG UK.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2016 Oct 17; Vol. 6, pp. 35364. Date of Electronic Publication: 2016 Oct 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Magnetic Resonance Imaging*
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*physiopathology
Aged ; Aged, 80 and over ; Area Under Curve ; Biomarkers, Tumor/metabolism ; Biopsy ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Probability ; Prospective Studies ; Prostate/pathology ; Reproducibility of Results
Czasopismo naukowe
Tytuł :
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
Autorzy :
Ross-Adams H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Lamb AD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK ; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK.
Dunning MJ; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Halim S; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Lindberg J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Massie CM; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Egevad LA; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Russell R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Ramos-Montoya A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Vowler SL; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Sharma NL; Nuffield Department of Surgical Sciences, University of Oxford, Roosevelt Drive, Oxford, UK.
Kay J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK.
Whitaker H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Molecular Diagnostics and Therapeutics Group, University College London, WC1E 6BT, UK.
Clark J; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
Hurst R; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK ; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK.
Shah NC; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Warren AY; Department of Pathology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Cooper CS; University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, UK.
Lynch AG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Stark R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK.
Mills IG; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Prostate Cancer Research Group, Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, N-0318 Oslo, Norway ; Department of Molecular Oncology, Institute of Cancer Research, Oslo University Hospitals, N-0424 Oslo, Norway ; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
Grönberg H; Academic Urology Group, University of Cambridge, Cambridge, CB2 0QQ, UK.
Neal DE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK ; Department of Urology, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
Pokaż więcej
Corporate Authors :
CamCaP Study Group
Źródło :
EBioMedicine [EBioMedicine] 2015 Jul 29; Vol. 2 (9), pp. 1133-44. Date of Electronic Publication: 2015 Jul 29 (Print Publication: 2015).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Dosage*
Prostatic Neoplasms/*genetics
Transcriptome/*genetics
Adult ; Aged ; Aged, 80 and over ; Cluster Analysis ; Cohort Studies ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genome, Human ; Humans ; Male ; Middle Aged ; Prognosis ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Recurrence ; Reproducibility of Results ; Risk Factors
Czasopismo naukowe
Tytuł :
Primary radical therapy selection in high-risk non-metastatic prostate cancer.
Autorzy :
Gnanapragasam VJ; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK; Translational Prostate Cancer Group, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK. Electronic address: .
Payne H; Department of Oncology, University College London, London, UK.
Syndikus I; Clatterbridge Cancer Centre, Wirral, UK.
Kynaston H; Department of Urology, University Hospital of Wales, Cardiff, UK.
Johnstone T; Academic Urology Group, Department of Surgery, University of Cambridge, Cambridge, UK.
Pokaż więcej
Źródło :
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2015 Mar; Vol. 27 (3), pp. 136-44. Date of Electronic Publication: 2014 Nov 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Prostatic Neoplasms/*radiotherapy
Disease Progression ; Humans ; Male ; Radiotherapy, Adjuvant ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.
Autorzy :
Shaw GL; 1] Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Thomas BC; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Dawson SN; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Srivastava G; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Vowler SL; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Gnanapragasam VJ; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Shah NC; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Warren AY; Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Neal DE; 1] Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK [2] Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK.
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2014 May 13; Vol. 110 (10), pp. 2405-11. Date of Electronic Publication: 2014 Apr 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Early Detection of Cancer*
Watchful Waiting*
Adenocarcinoma/*pathology
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*pathology
Adenocarcinoma/blood ; Adenocarcinoma/diagnosis ; Adenocarcinoma/surgery ; Aged ; Area Under Curve ; Biopsy, Needle ; False Negative Reactions ; Humans ; Lymphatic Metastasis ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Staging ; Organ Size ; Patient Selection ; Predictive Value of Tests ; Prostate/pathology ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/surgery ; ROC Curve ; Retrospective Studies ; Risk Assessment ; Seminal Vesicles/pathology ; Sensitivity and Specificity ; Tumor Burden
Czasopismo naukowe
Tytuł :
Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England.
Autorzy :
Greenberg DC; Public Health England, National Cancer Registration Service (Eastern Office), Cambridge CB22 3AD, UK.
Wright KA
Lophathanon A
Muir KR
Gnanapragasam VJ
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2013 Oct 15; Vol. 109 (8), pp. 2115-20. Date of Electronic Publication: 2013 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*epidemiology
Age Factors ; Aged ; Aged, 80 and over ; England/epidemiology ; Humans ; Incidence ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Grading ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Registries ; Risk Factors
Czasopismo naukowe
Tytuł :
Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.
Autorzy :
Kachroo N; Translational Prostate Cancer Group, Hutchison/MRC Research centre, University of Cambridge, Cambridge CB1 0XZ, UK.
Valencia T
Warren AY
Gnanapragasam VJ
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2013 Feb 19; Vol. 108 (3), pp. 597-601. Date of Electronic Publication: 2012 Nov 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dual Specificity Phosphatase 1/*genetics
Intracellular Signaling Peptides and Proteins/*genetics
Membrane Proteins/*genetics
Prostatic Hyperplasia/*genetics
Prostatic Neoplasms/*genetics
Receptors, Interleukin/*genetics
Repressor Proteins/*genetics
Adaptor Proteins, Signal Transducing ; Blotting, Western ; Cell Movement ; Cell Proliferation ; Cohort Studies ; Down-Regulation ; Dual Specificity Phosphatase 1/metabolism ; Humans ; Intracellular Signaling Peptides and Proteins/metabolism ; Male ; Membrane Proteins/metabolism ; Neoplasm Grading ; Prognosis ; Prostatic Hyperplasia/metabolism ; Prostatic Hyperplasia/pathology ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; RNA, Messenger/genetics ; RNA, Small Interfering/genetics ; Real-Time Polymerase Chain Reaction ; Receptors, Interleukin/metabolism ; Repressor Proteins/antagonists & inhibitors ; Repressor Proteins/metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study.
Autorzy :
Barrett T; Department of Radiology, Addenbrooke's Hospital and University of Cambridge, Cambridge, United Kingdom. />Gill AB
Kataoka MY
Priest AN
Joubert I
McLean MA
Graves MJ
Stearn S
Lomas DJ
Griffiths JR
Neal D
Gnanapragasam VJ
Sala E
Pokaż więcej
Źródło :
Magnetic resonance in medicine [Magn Reson Med] 2012 Mar; Vol. 67 (3), pp. 778-85. Date of Electronic Publication: 2011 Aug 29.
Typ publikacji :
Journal Article
MeSH Terms :
Androgen Receptor Antagonists/*therapeutic use
Anilides/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Diffusion Magnetic Resonance Imaging/*methods
Goserelin/*therapeutic use
Nitriles/*therapeutic use
Prostatic Neoplasms/*drug therapy
Tosyl Compounds/*therapeutic use
Aged ; Aged, 80 and over ; Contrast Media ; Feasibility Studies ; Humans ; Imaging, Three-Dimensional ; Male ; Middle Aged ; Organometallic Compounds ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Risk profiles of prostate cancers identified from UK primary care using national referral guidelines.
Autorzy :
Serag H; Department of Urology, Addenbrookes Hospital, Hills Road, Cambridge CB2 0XZ, UK.
Banerjee S
Saeb-Parsy K
Irving S
Wright K
Stearn S
Doble A
Gnanapragasam VJ
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2012 Jan 31; Vol. 106 (3), pp. 436-9. Date of Electronic Publication: 2012 Jan 12.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Benchmarking*
Practice Guidelines as Topic*
Referral and Consultation*
Prostatic Neoplasms/*epidemiology
State Medicine/*standards
Aged ; Cohort Studies ; Early Detection of Cancer/statistics & numerical data ; England/epidemiology ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prospective Studies ; Prostatic Neoplasms/etiology ; Prostatic Neoplasms/pathology ; Registries ; Risk Factors
Czasopismo naukowe
Tytuł :
Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer.
Autorzy :
Hori S; Translational Prostate Cancer Group, Department of Oncology, Hutchinson MRC Research Centre, University of Cambridge, Hills Road, Cambridge CB2 0XZ, UK.
Jabbar T
Kachroo N
Vasconcelos JC
Robson CN
Gnanapragasam VJ
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2011 Feb; Vol. 137 (2), pp. 235-41.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Orchiectomy*
Androgen Antagonists/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Biomarkers, Tumor/*blood
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*therapy
Aged ; Aged, 80 and over ; Analysis of Variance ; Bone Neoplasms/diagnosis ; Bone Neoplasms/secondary ; Cohort Studies ; Disease-Free Survival ; Gonadotropin-Releasing Hormone/agonists ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Staging ; Predictive Value of Tests ; Prognosis ; Prostatic Neoplasms/immunology ; Prostatic Neoplasms/pathology ; Reproducibility of Results ; Risk Assessment ; Risk Factors
Czasopismo naukowe
Tytuł :
Does a pre-operative urodynamic diagnosis of bladder outflow obstruction improve outcomes from palliative transurethral prostatectomy?
Autorzy :
Gnanapragasam VJ; Department of Urology, Addenbrooke's Hospital, Cambridge, UK. />Leonard A
Pokaż więcej
Źródło :
Urologia internationalis [Urol Int] 2011; Vol. 86 (1), pp. 85-9. Date of Electronic Publication: 2010 Aug 21.
Typ publikacji :
Journal Article
MeSH Terms :
Preoperative Care*
Transurethral Resection of Prostate*
Urodynamics*
Urinary Bladder Neck Obstruction/*diagnosis
Urinary Bladder Neck Obstruction/*surgery
Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies